Corporate
-
SIMPONI® Receives CHMP Positive Opinion For Treatment Of Non-Radiographic Axial Spondyloarthritis In Europe
SIMPONI Recommended for Approval in Adult Patients with Severe Active Non-Radiographic Axial Spondyloarthritis -
New Real-World Data Show Adults with Type 2 Diabetes, Including Those Taking Multiple Diabetes Medications, Achieve Blood Glucose Treatment Goals After Using INVOKANA®(canagliflozin)
Findings Also Show Some Patients Discontinue Use of Other Blood-Glucose-Lowering Medications after Initiation of INVOKANA® -
Real-World Data Presented at American Geriatrics Society Meeting Show Consistent Safety of XARELTO® in Elderly Patients
Results Add to Findings from Ongoing Five-Year Post-Marketing Safety Program of XARELTO® Use in Clinical Practice -
Janssen to Showcase Data from Five Compounds Including Daratumumab and IMBRUVICA at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting
·Note: This release corresponds to ASCO abstracts LBA8512, 8587, 8590, TPS8609, TPS8608, LBA7005, 7012, TPS8599, TPS8601, 7024, TPS7095, TPS7096, 5005, 5047, 5053, 5014, 5028, TPS5071, TPS5084, 10503, 6537, TPS5606 -
-
Johnson & Johnson Expands IP Policy to Create Broad Access in 128 Countries for Development of New and Optimized HIV Medicine Formulations for Children Living with HIV
Expanded Policy will Increase Access for Darunavir Pediatric Formulations in 128 Resource-Limited Countries -
-
Janssen Launches U.S. Hispanic Community Initiative to Help Improve Type 2 Diabetes Care
New research shows marked differences between Hispanic and non-Hispanic type 2 diabetes patients in disease perceptions and management approaches, highlighting need for tailored education among patients and healthcare professionals -
Ethicon’s HARMONIC FOCUS®+ Shears Now Proven To Produce Vessel Seal Strength Equivalent To Advanced Bipolar Devices
Ultrasonic device known for meticulous dissection now produces lower tissue temperature and less thermal damage critical when working near nerves
